Charmacy Pharmaceutical Co., Ltd. Stock price

Equities

2289

CNE1000023D6

Drug Retailers

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
10.4 HKD +4.00% Intraday chart for Charmacy Pharmaceutical Co., Ltd. -1.52% -19.75%

Financials

Sales 2021 3.79B 525M 4.11B Sales 2022 4.18B 578M 4.52B Capitalization 657M 90.98M 712M
Net income 2021 23M 3.18M 24.92M Net income 2022 90M 12.46M 97.5M EV / Sales 2021 0.31 x
Net Debt 2021 685M 94.88M 742M Net Debt 2022 682M 94.37M 739M EV / Sales 2022 0.32 x
P/E ratio 2021
21.2 x
P/E ratio 2022
7.27 x
Employees 811
Yield 2021 *
-
Yield 2022
7.4%
Free-Float 24%
More Fundamentals * Assessed data
Dynamic Chart
Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024 CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Charmacy Pharmaceutical’s Profit to Drop by 45% in 2023 MT
Charmacy Pharmaceutical Meets Minimum Public Float Norms MT
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Charmacy Pharmaceutical Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 31 July 2023 CI
Charmacy Pharmaceutical Chairman Steps Down MT
Charmacy Pharmaceutical Co., Ltd. Announces Board Changes CI
Charmacy Pharmaceutical Co., Ltd. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on July 31, 2023 CI
Charmacy Pharmaceutical's Controlling Shareholder Signs Letter of Commitment for Director Appointment; Shares Climb 6% MT
Charmacy Pharmaceutical Co., Ltd. Announces Resignation of Executives CI
Charmacy Pharmaceutical Co., Ltd. Recommends Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 20 July 2023 CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Charmacy Pharmaceutical Renews Loan Provision Deal with Controlling Shareholder MT
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders. CI
More news
1 day+4.00%
1 week-1.52%
Current month-10.03%
1 month-10.34%
3 months-19.88%
6 months-20.25%
Current year-19.75%
More quotes
1 week
9.01
Extreme 9.01
10.58
1 month
9.01
Extreme 9.01
11.70
Current year
8.86
Extreme 8.86
13.02
1 year
5.90
Extreme 5.9
20.00
3 years
4.46
Extreme 4.46
20.00
5 years
4.01
Extreme 4.01
20.00
10 years
4.01
Extreme 4.01
20.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 00-03-05
Director of Finance/CFO 45 22-07-12
Director/Board Member 40 -
Members of the board TitleAgeSince
Chief Executive Officer 54 00-03-05
Director/Board Member 49 -
Director/Board Member 48 15-11-30
More insiders
Date Price Change Volume
24-03-28 10.4 +4.00% 1,000
24-03-27 10 0.00% 0
24-03-26 10 -5.48% 2,538,500
24-03-25 10.58 +0.19% 1,010,500
24-03-22 10.56 0.00% 0

Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT

More quotes
Charmacy Pharmaceutical Co., Ltd. is principally engaged in pharmaceutical products distribution in the People's Republic of China (the PRC). The products also include healthcare medicine, traditional Chinese drinking tablets, traditional Chinese medicine and medical equipment. Through its subsidiaries, the Company is also engaged in the trading of pharmaceutical products and provision of related services.
More about the company
  1. Stock
  2. Equities
  3. Stock Charmacy Pharmaceutical Co., Ltd. - Hong Kong S.E.